Wyatt, Monique A.
Pisarski, Emily E.
Kriel, Yolandie
Smith, Patricia M.
Mathenjwa, Mxolisi
Jaggernath, Manjeetha
Smit, Jennifer A.
Matthews, Lynn T.
Ware, Norma C. http://orcid.org/0000-0002-5039-9991
Funding for this research was provided by:
National Institutes of Health (NIMH R01MH108412)
Article History
Accepted: 11 June 2022
First Online: 30 June 2022
Declarations
:
: The authors have no conflict of interest to disclose.
: The ZINK Study was approved by: (1) the Human Research Ethics Committee at the University of Witwatersrand (Johannesburg, South Africa); (2) the University of Alabama at Birmingham Institutional Review Board for Human Use (Birmingham, AL, USA); and (3) the Institutional Review Board of Partners Healthcare (Boston, MA, USA). The ZINK Study protocol is registered at ClinicalTrial.gov (NCT02194308) and at the South African Health Products Regulatory Agency (SAHPRA) (MCC#20170131).
: All participants provided written consent before taking part in the ZINK Study.
: Not applicable.
Free to read: This content has been made available to all.